Skip to main content
. 2024 Nov 14;22:303. doi: 10.1186/s12957-024-03585-1

Table 1.

Clinicopathologic characteristics of patients

Characteristics Without bypass (n = 27) With bypass (n = 23) p-value
Age, years 53 (27–76) 51 (28–76) 0.498
Gender 0.665
   Male 16 (59.3) 15 (65.2)
   Female 11 (40.7) 8 (34.8)
BMI 0.859
   Normal 12 (44.4) 10 (43.5)
   Overweight 12 (44.4) 9 (39.1)
   Obesity 3 (11.1) 4 (17.4)
Symptoms 0.005
   Bleeding 10 (37.0) 3 (13.0)
   Abdominal discomfort 5 (18.5) 12 (52.2)
   Palpable mass 0 3 (13.0)
   Asymptomatic 12 (44.4) 5 (21.7)
Diabetes 0.460
   Yes 0 1 (4.3)
   No 27 (100) 22 (95.7)
Smoking 0.670
   Yes 9 (33.3) 9 (39.1)
   No 18 (66.7) 14 (60.9)
Hemoglobin, g/L 118 (81–166) 118 (69–157) 0.943
Tumor size, cm 6 (2–22) 9 (3–28) 0.005
Risk classification 0.104
   Very low 1 (3.7) 0
   Low 9 (33.3) 3 (13.0)
   Intermediate 0 0
   High 17 (63.0) 20 (87.0)
Location 0.449
   Duodenum 23 (85.2) 22 (95.7)
   Proximal jejunum 4 (14.8) 1 (4.3)
Liver metastases 0.094
   No 18 (66.7) 20 (87.0)
   Yes 9 (33.3) 3 (13.0)
Neoadjuvant therapy 0.449
   No 16 (59.3) 16 (69.6)
   Yes 11 (40.7) 7 (30.4)
ASA 0.225
   I 1 (3.7) 4 (17.4)
   II 24 (88.9) 16 (69.6)
   III 2 (7.4) 3 (13.0)
Operative time, min 230 (100–490) 311 (142–557) 0.017
Intraoperative bleeding, ml 100 (20-2000) 200 (20-3000) 0.084
Multi-visceral resection 0.869
   No 17 (63.0) 15 (65.2)
   Yes 10 (37.0) 8 (34.8)
ICU admission 0.159
   No 25 (92.6) 17 (73.9)
   Yes 2 (7.4) 6 (26.1)
Complication 1.000
   < 3 24 (88.9) 21 (91.3)
   ≥ 3 3 (11.1) 2 (8.7)
Highest body temperature, ℃ 37.8 (36.9–39.1) 37.7 (36.8–39.0) 0.453
Postoperative stays, days 28 (6–75) 14 (10–56) 0.070
DGE 0.028
   0-A 7 (25.9) 13 (56.5)
   B-C 20 (74.1) 10 (43.5)
NGT removal, days 8 (5–70) 7 (3–39) 0.090
NGT reinsertion 0.435
   No 20 (74.1) 20 (87.0)
   Yes 7 (25.9) 3 (13.0)